6N83
Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | CLSI BEAMLINE 08ID-1 |
| Synchrotron site | CLSI |
| Beamline | 08ID-1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2018-06-23 |
| Detector | MARMOSAIC 300 mm CCD |
| Wavelength(s) | 0.97949 |
| Spacegroup name | P 41 21 2 |
| Unit cell lengths | 111.080, 111.080, 76.730 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 78.670 - 2.000 |
| R-factor | 0.18802 |
| Rwork | 0.186 |
| R-free | 0.21745 |
| Structure solution method | FOURIER SYNTHESIS |
| Starting model (for MR) | 4xqr |
| RMSD bond length | 0.014 |
| RMSD bond angle | 1.669 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | REFMAC |
| Refinement software | REFMAC (5.8.0230) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 111.080 | 2.030 |
| High resolution limit [Å] | 2.000 | 2.000 |
| Rmerge | 0.043 | 1.375 |
| Rmeas | 0.045 | 1.431 |
| Rpim | 0.013 | 0.392 |
| Number of reflections | 32849 | 1609 |
| <I/σ(I)> | 25.7 | 2.2 |
| Completeness [%] | 99.3 | 99 |
| Redundancy | 13 | 13.1 |
| CC(1/2) | 0.999 | 0.861 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 295 | 0.08 M TrisHCl ph 8.5, 1.6 M Ammonium phosphate, 20% (v/v) glycerol |
